ArticleJournal of the American Academy of Orthopaedic Surgeons. Global research & reviews2026
Assessing Patient Characteristics That Prolong the Need for Total Hip Arthroplasty Following Surgeon-Administered Intra-articular Corticosteroid Injections.
Article in Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of studyAlthough intra-articular corticosteroid hip injections may only delay an inevitable surgery, patient-specific factors and individual psychosocial factors that might dissuade immediate surgery are not fully understood. The purpose of this study was to understand the diverse reasons that patients elect to undergo hip injections and the various timelines to total hip arthroplasty (THA).
methodsA retrospective review was conducted at a single academic medical center identifying all consecutive patients who had undergone fluoroscopically guided intra-articular surgeon-administered corticosteroid hip injections between June 2018 and February 2023. Data collected included baseline demographics, hip radiographic variables, duration of postinjection pain relief, and if THA was performed. Univariate and multivariate logistic regression analyses identified predictors associated with undergoing THA within 6 and 12 months postinjection.
resultsA total of 93 patients (22 bilateral) with average age of 59.8 ± 1.6 years and body mass index of 31.0 ± 6.3 kg/m2 were reviewed. Reasons for hip injection included the following: 39% due to fear or anxiety of THA; 33% for diagnostic purposes, primarily to discern if the pain stemmed from another source such as the lumbar spine or knee. Most patients showed advanced osteoarthritis: 44% Kellgren-Lawrence (K-L) grade 3 and 35% K-L grade 4. After injection, the average reported pain relief duration was 3.8 ± 4.9 months. Smoking markedly increased the likelihood of undergoing THA within 6 months (OR = 10.889; P = 0.001) and 12 months (OR = 6.375; P = 0.008).
conclusionThis study elucidated the multifaceted reasons patients opt for conservative management through corticosteroid hip injections. The value of patient-centered care is emphasized in managing hip osteoarthritis, as shown in the high patient retention rates postinjection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.